High Potency Active Pharmaceutical Ingredients Represent the Fastest Growth Areas

Monday 15 October 2012, Amsterdam

According to a new research report "Global API Market Analysis", High Potency Active Pharmaceutical Ingredients (HPAPIs) represent the fastest growing segment in the Global RNAi industry and is driving the API market to a more innovative future. These compounds are extremely effective in the treatment of cancers, respiratory disorders, and hormonal imbalances and the market for HPAPIs is mostly driven by the growth in the oncology therapeutics market worldwide. The global HPAPI market is expected to diversify greatly and show a robust CAGR of 8.7% from 2011-2015.

The global API industry is placed at a very promising position with the growth in the global pharma and rising diseases. Particularly, the Asia-Pacific regions are emerging fast primarily due to their significant production of biogenerics. Specifically, India and China are emerging as global hubs in the global API market. Biotech APIs are growing robustly due to their high utility and their effectiveness in treating complex diseases. According to the latest report by RNCOS, "Global API Market Analysis", the worldwide API market size is likely to register a healthy CAGR of around 8% during 2012-2015.

The report spread in over 75 pages provides an understanding of the API market globally and its current state. The key industry drivers have been covered in detail along with the current and future market projections for 2012-2015. The major segments and sub-segments of the API industry have been covered along with the description of the API industry in the most promising geographies of India, China, Italy, and Taiwan. The report also analyzes the opportunity assessment for companies in the global APIs market in terms of therapeutic segments and countries' comparative index.  An analysis of the emerging areas, competitive landscape and regulatory stringency further provides a holistic understanding of the global API market.